Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $9.1M | $20.0M | $39.9M | $63.1M | $69.6M | $83.6M | $78.6M |
| Operating income | −$13.0M | −$27.5M | −$58.1M | −$86.4M | −$91.9M | −$115.4M | −$108.5M |
| EBITDA | −$12.5M | −$26.7M | −$58.1M | −$84.4M | −$89.9M | −$115.4M | −$106.3M |
| Net income | −$13.3M | −$28.0M | −$53.9M | −$85.7M | −$93.7M | −$122.2M | −$114.5M |
| Net margin | — | — | — | — | — | — | — |
| EPS (diluted) | -94.06 | -149.55 | -49.25 | -53.49 | -47.45 | -46.18 | -26.28 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-1.40 | $-1.40–$-1.40 | 1 |
| 2027 | $0 | $-1.40 | $-1.40–$-1.40 | 1 |
Forward consensus · source: Financial Modeling Prep
EVELO BIOSCIENCES INC
No one on the platform currently holds EVLO.
No tracked institution reports a position in EVLO as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-06-30 | 1-for-20reverse |
| 2006-06-29 | 1-for-100reverse |
No one on the platform has traded EVLO yet.
| $5365 |
| — |
| INFIQInfinity Pharmaceuticals, Inc. | $0.00 | +0.00% | $9076 | — |
| LIFSLife Stem Genetics Inc. | $0.00 | +0.00% | $4584 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Fundamental analysis of $EVLO (Evelo Biosciences, Inc.) based on financial data and reported results. #EVLO
View on StockTwits ↗$EVLO Interesting biotech play. SINTAX platform looks promising but recent clinical failures raise red flags. Watching closely for strategic alternatives or potential partnership. Might be a speculative entry for risk-tolerant investors. standout article: https://beyondspx.com/article/evelo-biosciences-inc-evlo-exploring-the-potential-of-sintax-medicines
View on StockTwits ↗$EVLO Evelo Biosciences, Inc. (NASDAQ:EVLO): Navigating the Challenges of a Development-Stage Biotech https://beyondspx.com/article/evelo-biosciences-inc-evlo-navigating-the-challenges-of-developing-a-novel-therapeutic-approach
View on StockTwits ↗$EVLO Evelo Biosciences, Inc. (EVLO): Navigating the Challenges of Developing a Novel Therapeutic Approach https://beyondspx.com/article/evelo-biosciences-inc-evlo-navigating-the-challenges-of-developing-a-novel-therapeutic-approach
View on StockTwits ↗$MCRB Nestlé knows the remaining pipeline is too risky to acquire the whole company, it's likely to fail. MCRB was founded by Flagship Pioneering so be careful here, this may end up like $EVLO and $KLDO (failed Flagship Pioneering's microbiome companies).
View on StockTwits ↗@barbarios it’s also strange that Kldo shareholders didn’t get a chance to vote on the winding down. $evlo on the other hand, held a special meeting of stakeholders to vote on the winding down.
View on StockTwits ↗$EVLO I will be very happy if I see this hit $0.07 today.
View on StockTwits ↗$MCRB I am watching this as a turnaround play $EVLO $KLDO went bankrupt in space they are last one left - I think this space has potential despite many setbacks. @Monkey_Banana_Genius Wonder if nestle buys them out, the amount of research in microbiome has exploded last 5 years . Might get 10k and leave it
View on StockTwits ↗$EVLO $MCOM $SMFL Looks like Miami is stubborn in SMFL. Volume in all three can bring good Christmas. SMFL volume is insane
View on StockTwits ↗$EVLO Before anything else we need message volume between now and Jan 26th. Go EVLO. Wake up 1895 Watchers
View on StockTwits ↗$EVLO $SMFL $MCOM are choice of the day. Is Christmas here already? Good Luck. Share your thoughts as well. as always do your math and DD
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.